Abbvie Inc (NYSE:ABBV)
Abbvie Inc
NYSE:ABBV
EV/EBIT
Enterprise Value to EBIT
The Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
EV/EBIT
= Enterprise Value
/ EBIT
Current EV/EBIT
ABBV
16.1
Median EV/EBIT
ABBV
15.6
Industry EV/EBIT
Biotechnology
2.2
EV/EBIT History
Statistics
Enterprise Value to EBIT
Enterprise Value to EBIT
| 1 Year | 3 Years | 5 Years | |
|---|---|---|---|
| Average | 15.8 | 14.7 | 14.2 |
| Median | 15.8 | 15.6 | 14.3 |
| Min | 14 | 8.6 | 8.6 |
| Max | 19.3 | 21 | 21 |
History Chart
Enterprise Value to EBIT
Enterprise Value to EBIT
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBIT
10.4
2-Years Forward
EV/EBIT
12.1
3-Years Forward
EV/EBIT
12.2
EV/EBIT Across Competitors
ABBV Competitors
Abbvie Inc Competitors
Abbvie Inc Competitors
Relative Valuation Report
View full relative valuation report for Abbvie Inc, which takes into account all ABBV`s valuation multiples.
